Eficácia e segurança da ventilação não-invasiva no manejo do choque cardiogénico.

Cardiogenic shock (CS) has long been considered a contraindication for the use of non-invasive ventilation (NIV). The main objective of this study was to analyze the effectiveness, measured as NIV success, in patients with respiratory failure due to CS. As secondary objective, we studied risk factors for NIV failure and compared the outcome of patients treated with NIV versus invasive mechanical ventilation (IMV). Retrospective study on a prospective database, over a period of 25 years, of all consecutively patients admitted to an Intensive Care Unit, with a diagnosis of CS and treated with NIV. A comparison was made between patients on NIV and patients on IMV using propensity score matching analysis. 300 patients were included, mean age 73.8 years, mean SAPS II 49. The main cause of CS was acute myocardial infarction (AMI): 164 (54.7%). NIV failure occurred in 153 (51%) cases. Independent factors for NIV failure included D/E stages of CS, AMI, NIV related complications, and being transferred from the ward. In the propensity analysis, hospital mortality (OR 1.69, 95%-CI 1.09-2.63) and 1 year mortality (OR 1.61, 95%-CI 1.04-2.51) was higher in IMV. Mortality was lower with NIV (vs EIT-IMV) in C stage (10.1% vs 32.9%; p < 0.001) but did not differ in D stage or E stage. NIV seems to be relatively effective and safe in the treatment of early-stage CS.

Informations de copyright

Copyright © 2023. Publicado por Elsevier España, S.L.U.